Minh Tam Truong, MBBS, MBA Hear my name
Professor
Boston University Chobanian & Avedisian School of Medicine
Radiation Oncology

MBBS, University of New South Wales
BSc, University of New South Wales

Pronouns: she/her/hers



Dr. Truong is the Chair and Professor of Radiation Oncology at Boston University Chobanian and Avedisian School of Medicine, and Chief of Radiation Oncology at Boston Medical Center.

She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. She also holds a Master’s of Business Administration from Boston University’s Questrom School of Business.

She is an internationally recognized expert in the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including post operative radiation for the prevention of Keloids, Airway Amyloidosis, Graves Orbitopathy.

Dr. Truong serves on a several national committees with leadership roles within the American Society for Therapeutic Radiation Oncology (ASTRO), the American Board of Radiology (ABR), and NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)).

She is the Quality of Life Co-Chair on several international head and neck cancer multicenter trials conducted by the NRG Oncology group and has been instrumental in the prospective trial design of the Quality of Life and Patient Reported Outcome sub-studies on these trials.

She also contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board for over 15 years.

At Boston Medical Center, she maintains a busy clinical practice and supports many research activities at Boston Medical Center and Boston University. Over the past two decades, she has taught and mentored many Boston University Medical Students, over 80 physician residents in the Harvard Radiation Oncology Program, and Boston University physician faculty. She is actively involved in promoting clinical research activities at Boston Medical Center and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and was a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.

Her research has resulted in over 100 peer-reviewed scientific publications, editorials, book chapters, and invited reviews.

In 2022, Dr Truong was awarded the Fellow of the American Society of Radiation Oncology for her contributions to the field of Radiation Oncology and service to ASTRO.

Since 2017 to 2024, she has been named Top Doctor in Castle Connolly’s America’s Top Doctors, Exceptional Women in Medicine, and Boston Magazine.

Chair
Boston University Chobanian & Avedisian School of Medicine
Radiation Oncology


Member
Boston University
BU-BMC Cancer Center


Member
Boston University
Amyloidosis Center


Chief
Boston Medical Center
Radiation Oncology


VA Boston Healthcare System





NRG-TMIST
08/01/2014 - 02/28/2025 (PI)
NRG Oncology Foundation, Inc. National Cancer Inst
5UG1CA189867-10

Cancer Survivorship Clinic Navigation Program
04/01/2017 - 04/30/2019 (PI)
Harvard Pilgrim Health Care / HPHC


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Huang D, Qureshi MM, Truong MT, Hirsch AE. Correlation Between Research Productivity During Medical School and Radiation Oncology Residency. Adv Radiat Oncol. 2023; 8(4):101219.View Related Profiles. PMID: 37124315; PMCID: PMC10130758; DOI: 10.1016/j.adro.2023.101219;
     
  2. Qureshi MM, Kam A, Suzuki K, Litle V, Tapan U, Balasubramaniyan R, Dyer MA, Truong MT, Mak KS. Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer. Surgery. 2023 May; 173(5):1153-1161.View Related Profiles. PMID: 36774317
     
  3. Oladeru OT, Lam CM, Qureshi MM, Hirsch AE, Mak KS, Dyer MA, Truong MT. Inequalities in Cancer Stage at Diagnosis Among Incarcerated Individuals Undergoing Radiation Therapy at a Large Safety-Net Hospital. Int J Radiat Oncol Biol Phys. 2023 May 01; 116(1):194-198.View Related Profiles. PMID: 36758643
     
  4. Dang RR, Kim J, Qureshi MM, Fazeli SR, Zhao Q, Noonan VL, Sundararajan D, Salama A, Truong MT. Impact of depth of invasion on local recurrence in R0 resected node-negative oral tongue squamous cell carcinoma. Head Neck. 2023 Mar; 45(3):561-566.View Related Profiles. PMID: 36513522
     
  5. Gillison ML, Ferris RL, Harris J, Colevas AD, Mell LK, Kong C, Jordan RC, Moore KL, Truong MT, Kirsch C, Chakravarti A, Blakaj DM, Clump DA, Ohr JP, Deeken JF, Gensheimer MF, Saba NF, Dorth JA, Rosenthal DI, Leidner RS, Kimple RJ, Machtay M, Curran WJ, Torres-Saavedra P, Le QT. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504. Int J Radiat Oncol Biol Phys. 2023 Mar 15; 115(4):847-860. PMID: 36228746
     
  6. Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT. 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002. J Nucl Med. 2023 Mar; 64(3):362-367. PMID: 36215572; PMCID: PMC10071810; DOI: 10.2967/jnumed.122.264424;
     
  7. Lam CM, Qureshi MM, Patel PN, Park JJ, Dang RR, Rubin SJ, Salama AR, Truong MT. Oral cancer patients achieve comparable survival at high safety-net burden hospitals. Am J Otolaryngol. 2022 May-Jun; 43(3):103438.View Related Profiles. PMID: 35489110
     
  8. Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, Oladeru OT, Truong MT, Hirsch AE, Mak KS, Dyer MA. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol. 2022 01; 164(1):27-33.View Related Profiles. PMID: 34785030; PMCID: PMC8711036; DOI: 10.1016/j.ygyno.2021.10.028;
     
  9. Huang D, Qureshi MM, Sarfaty S, Truong MT, Dyer MA, Mak KS, Hirsch AE. Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative. J Cancer Educ. 2023 Feb; 38(1):153-160.View Related Profiles. PMID: 34558038; DOI: 10.1007/s13187-021-02091-2;
     
  10. Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Truong MT, Hirata K, Yasuda K, Kano S, Homma A, Kudo K, Sakai O. Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images. BMC Cancer. 2021 Aug 06; 21(1):900.View Related Profiles. PMID: 34362317; PMCID: PMC8344209; DOI: 10.1186/s12885-021-08599-6;
     
Showing 10 of 98 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 98 publications over 18 distinct years, with a maximum of 12 publications in 2018

YearPublications
20031
20041
20062
20092
20101
20115
201210
20137
20147
20155
20161
201710
201812
201910
20209
20218
20224
20233

2024 National Cancer Institute PDQ Editorial Board: 15 year Service Award
2022 American Society of Radiation Oncology (ASTRO): Fellow of ASTRO
2019-2024 Castle Connolly: Exceptional Women in Medicine
2017-2024 Boston Magazine Top Doctors: Top Doctor
2017-2024 Castle Connolly’s America’s Top Doctors: Top Doctor
2013 Annals of Nuclear Medicine Vol 26. 2012: Bronze Prize, Best Three Papers
2011 RSNA annual scientific meeting 2011: Certificate of Merit
2010 National Cancer Institute, Physician Data Query (PDQ) Editorial Board : National Institutes of Health Merit Award
2010 RSNA annual scientific meeting 2010: Cum Laude
2008 RSNA annual scientific meeting 2008: Certificate of Merit
2003 Radiological Society of North America: Roentgen Resident Research Award

Students interested in oncology, radiation oncology, head and neck cancer, skin cancer, brain tumors, quality of life and outcomes research. Students interested in gaining exposure to novel technology for cancer therapy including Stereotactic Radiosurgery, Cyberknife Radiosurgery for brain tumors, recurrent head and neck cancer, metastatic disease.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Diversity Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
  • Assistant
         Name: Monica Ryl
         Email: monica.ryl@bmc.org
         Phone: 6176387057

818 Harrison Ave
Boston MA 02118
Google Map

(617)630-7037 (fax)

Truong's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department